Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 6,302 | 7,314 | 1,237 | 6,986 | 5,777 |
| Cost of Goods | 1,745 | 2,189 | 367 | 2,433 | 1,645 |
| Gross Profit | 4,557 | 5,125 | 870 | 4,553 | 4,132 |
| Operating Expenses | 26,907 | 27,876 | 27,495 | 36,578 | 30,244 |
| Operating Income | -21,605 | -22,562 | -26,258 | -31,592 | -25,467 |
| Interest Expense | 932 | 975 | 957 | 933 | 799 |
| Other Income | -11,806 | 11,255 | 9,791 | 23,513 | -22,383 |
| Pre-tax Income | -34,343 | -12,282 | -17,424 | -9,012 | -48,649 |
| Income Tax | 976 | 25 | -12 | -1,129 | -1,084 |
| Net Income Continuous | -35,319 | -12,307 | -17,412 | -7,883 | -47,565 |
| Net Income | $-35,319 | $-12,307 | $-17,412 | $-7,883 | $-47,565 |
| EPS Basic Total Ops | -1.55 | -0.65 | -1.20 | 10.01 | -3.71 |
| EPS Basic Continuous Ops | -1.55 | -0.65 | -1.23 | 9.99 | -3.71 |
| EPS Diluted Total Ops | -1.55 | -0.65 | -1.20 | 10.01 | -3.71 |
| EPS Diluted Continuous Ops | -1.55 | -0.65 | -1.23 | 9.99 | -3.71 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.07 | -0.12 | -0.60 | -3.70 |
| EBITDA(a) | $-24,958 | $-22,868 | $-26,207 | $-31,240 | $-24,936 |